Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for cannabis dependence in young people
2013-000361-36Phase 2Terminated
- Sponsor
- Joint Research Office
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in cannabis use disorder (CUD) (4 arms), sponsored by Joint Research Office. Primary endpoints: Stage 1 cannabis use reduction and Stage 2 remission of cannabis dependence and cessation. Started Aug 2013; status: terminated.
02
Drugs
cannabidiol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on 2013-000361-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000361-36.